At Access Accelerated, our efforts are focused on SDG 3.4 – by 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being; and SDG 17 – strengthen the means of implementation and revitalize the global partnership for sustainable development. Achieving these SDGs will require deeper commitments to tackling the NCD crisis; greater investments in health systems; and persistent mobilization across sectors and across borders. That’s why Access Accelerated adopted a new strategic framework; one that reinvigorates our steering committee, member companies and partners in tackling the global burden of NCDs while providing a clear and actionable path for maximizing impact to communities worldwide.


For the first Access Today newsletter of 2020, we explore three ways the biopharmaceutical industry and global health community can work together to make our shared goals a reality. Read more.